首页> 外文期刊>Journal of Diabetes Science and Technology >First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy
【24h】

First User Experiences With a Novel Touchscreen-Based Insulin Pump System in Daily Life of Patients With Type 1 Diabetes Experienced in Insulin Pump Therapy

机译:在基于胰岛素泵治疗的1型糖尿病患者日常生活中,使用基于触摸屏的新型胰岛素泵系统的首次用户体验

获取原文
       

摘要

Introduction: A new insulin pump system was tested under everyday conditions for user evaluation and safety assessment prior to its launch in Europe. This insulin pump is focused on easy handling and uses prefilled cartridges. Methods: The pump system was used by 35 adult subjects with type 1 diabetes, experienced in insulin pump therapy, under everyday conditions for approximately one month each. All subjects rated various aspects of the system after home use; technical issues and safety parameters were assessed throughout the study. Results: All 35 subjects completed the study as planned and used the system for a total of 1013 days. After home use, 74% of the subjects were very satisfied or quite satisfied with the new pump. The subjects confirmed that the system is easy to use, especially considering general handling, bolus delivery and basal rate settings, infusion set, and cartridge change. Potential for improvements was seen in the touchscreen, warnings and alarms, the blind bolus function, the availability of a bolus calculator (was not available at time of study), and the cartridge size as rated by the study participants. Safety analysis did not raise any concerns for the use of this system. Conclusion: The majority of the users testing the system were satisfied with the novel insulin pump system and the system was safe for use under everyday conditions by this study population.
机译:简介:新的胰岛素泵系统在投放欧洲市场之前,已在日常条件下进行了测试,以进行用户评估和安全评估。这款胰岛素泵专注于易于操作,并使用预装药筒。方法:该泵系统由35位在胰岛素泵治疗方面经验丰富的成年1型糖尿病成年人使用,每天大约需要一个月。所有受试者在家庭使用后都对系统的各个方面进行了评分;在整个研究过程中评估了技术问题和安全参数。结果:所有35名受试者均按计划完成了研究,并使用该系统共1013天。家用后,有74%的受试者对新泵非常满意或相当满意。受试者确认该系统易于使用,特别是考虑到一般处理,推注输送和基础剂量设置,输液器和药筒更换的情况。在触摸屏,警告和警报,盲注推注功能,推注计算器的可用性(在研究时不可用)以及研究参与者评估的墨盒尺寸中都看到了改进的潜力。安全分析并未引起对该系统使用的任何担忧。结论:测试该系统的大多数用户对新型胰岛素泵系统感到满意,并且该研究人群在日常条件下均可安全使用该系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号